Summary: Chronus Health has developed an electrical sensing-based, real-time blood testing system, aiming to reduce diagnostic time and healthcare costs by enabling on-site blood analysis.
Takeaways:
- Comprehensive Testing Capability: Chronus Health’s platform supports cell counting, chemistry assays, and immunoassays, offering a unique and cost-effective solution for point-of-care blood testing.
- Technological Innovation: Utilizing microfluidic sensors, machine learning, and aptamers, the system can conduct multiple blood panels outside traditional labs, streamlining the diagnostic process.
- Impact on Healthcare: The technology promises faster and more accurate test results at the point of care, improving patient outcomes and provider satisfaction, with a planned clinical trial and showcase at the ADLM 2024 conference.
Chronus Health, a provider in point-of-care diagnostics, has developed an electrical sensing-based, real-time blood testing system for use in urgent care centers, skilled nursing facilities, infusion centers, retail clinics, as well as primary care and specialty clinics.
This technology is designed to reduce the time to diagnosis and lower overall healthcare costs since blood samples are analyzed on-site rather than sent to central labs for analysis.
About Chronus Health’s New Platform
Chronus Health’s platform can uniquely support cell counting, chemistry assays (electrolytes, small molecules, and proteins), and immunoassays (proteins). This comprehensive solution has remained elusive until now, as past attempts to miniaturize existing technologies have lacked technical feasibility and cost-effectiveness, the company says.
Testing Outside a Lab
By leveraging a proprietary electrical sensing approach that integrates microfluidic sensors, machine learning, and aptamers, Chronus is poised deliver a platform capable of testing multiple blood panels outside the central lab setting. With 60% of all blood tests conducted outside hospitals, the company is at the forefront of providing fast and accurate blood testing at the point of care, at a lower price point.
“No one likes waiting for blood test results — neither doctors, nor patients or their families,” says Caesar Djavaherian, MD, co-founder and chief clinical innovation officer of Carbon Health. “Now we have a technology that can cost-effectively provide results at the point of care, leading to better patient outcomes and increased provider satisfaction. We look forward to launching a clinical trial using the Chronus system soon.”
Chronus Health will showcase its platform at the Association for Diagnostics & Laboratory Medicine (ADLM) 2024 conference, taking place in Chicago from July 28 to August 1, 2024.
“We are creating a new era for point-of-care testing, with a platform slated to revolutionize the diagnostics industry,” says Anand Parikh, CEO and Co-Founder of Chronus Health. “The foundation of processing lab work has remained the same for decades, and just as other industries have benefited from the innovation in electrical technology, so too will healthcare.”
Featured image: Chronus Health unveils its electrical sensing-based blood testing technology at ADLM 2024. Photo: Chronus Health
